"I want to emphasize CLI's willingness to participate in a cooperative process," but such changes should "be based on sound science."

— Glenn Davies, OD, an employee of Bausch & Lomb (Rochester, New York) who spoke on behalf of the Contact Lens Institute (CLI; Raleigh, North Carolina) before FDA's ophthalmic devices advisory committee. FDA convened the panel in response to persistent and frequent reports of keratitis associated with contact lens wear, "Lens solution makers need to account for 'human factors'", pp. 1, 6.